IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Nephrocare Health Services IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ [●] Cr. The company is based in Hyderabad and caters to Healthcare sector. Ambit , ICICI Securities , IIFL Securities , Nomura Financial Advisory And Securities (India) are the merchant bankers of Nephrocare Health Services IPO. It is a MainBoard Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 25th July 2025.
Nephrocare Health Services IPO posted revenues of ₹ 755.81 Cr. and PAT of ₹ 67.10 Cr. in FY25 on annualised basis.
Revenue:
₹ 755.81 Cr.
EBITDA Margin:
22.05
% 
Net Worth: ₹ 584.11 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: 0.60 times
Financial results of Nephrocare Health Services IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY25 | FY24 | FY23 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 996.46 | 806.02 | 666.23 | ||
| Net Worth | 584.11 | 413.71 | 388.63 | ||
| Total Debt | 225.80 | 243.36 | 196.21 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
755.81 | 566.16 | 437.29 | ||
EBITDA
EBITDA on annualised basis |
166.64 | 99.66 | 48.60 | ||
PAT
PAT on annualised basis |
67.10 | 35.13 | -11.79 | ||
Nephrocare Health Services IPO PAT Margin is 8.88 % , ROCE (Return on Capital Employed) is 18.67 % as per latest financial. The below table shows Nephrocare Health Services IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY25 | FY24 | FY23 |
|---|---|---|---|
| EBITDA Margin (%) | 22.05 | 17.60 | 11.11 |
| PAT Margin (%) | 8.88 | 6.20 | -2.70 |
| EPS (₹) | 8.28 | 4.55 | -1.53 |
| ROE (%) | 11.49 | 8.49 | -3.03 |
| ROCE (%) | 18.67 | 10.00 | 0.44 |
| ROA (%) | 6.73 | 4.36 | -1.77 |
| Debt to Equity | 0.39 | 0.59 | 0.50 |
The market Capitalisation of Nephrocare Health Services IPO is ₹ [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Nephrocare Health Services IPO prospectus highlights an Return on Equity (ROE) of 11.49 % , Return on Assets (ROA) of 6.73 %, and an EBITDA Margin of 22.05 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Nephrocare Health Services IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Nephrocare Health Services IPO is ₹ [●] Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Nephrocare Health Services IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Nephrocare Health Services IPO reported revenue of ₹ 755.81 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Nephrocare Health Services IPO provide insights into sales growth, market demand, and business scalability.
Nephrocare Health Services recorded an EBITDA of ₹ 166.64 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Nephrocare Health Services Profit After Tax (PAT) is ₹ 67.10 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 755.81 Cr.
EBITDA Margin:
22.05
%
Net Worth: ₹ 584.11 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA:
[●]
Nephrocare Health Services operates in Healthcare and Offers Comprehensive Dialysis Care. The Issue is listed on BSE,NSE in Jul, 2025. Nephrocare Health Services IPO size was with Issue price of .
Merchant Banker(s) of Nephrocare Health Services IPO: Ambit Private Limited , ICICI Securities Limited , IIFL Securities Limited , Nomura Financial Advisory And Securities (India) Private Limited
Nephrocare Health Services IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Nephrocare Health Services IPO listed at a listing price of against the offer price of .
The current market price of Nephrocare Health Services is .
Why Us?
